<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 21 Jul 2026 09:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Stereotaxis+to+Report+Second+Quarter+2026+Financial+Results+on+August+11%2C+2026/26793231.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  21, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=bhnQCBkUjyct7VX2izjefvwNrxr9af92644FSyyU3HySxsgMm-GtSi-c197ywFjwqzNp-5gpVN0l_QlexumndQ8Gv8nlJ0HlvITZm-de0pg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Stereotaxis, Inc.&lt;/a&gt; (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 second quarter on Tuesday, August 11, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the Company’s results and corporate developments.&lt;/p&gt; &lt;table style=&quot;border-collapse: collapse; width:100%; border-collapse:collapse ;&quot;&gt;&lt;tr&gt;&lt;td style=&quot;max-width:25%; width:25%; min-width:25%;;vertical-align: top ; &quot;&gt;&lt;strong&gt;What:&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;max-width:75%; width:75%; min-width:75%;;vertical-align: top ; &quot;&gt;Stereotaxis second</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Stereotaxis+to+Report+Second+Quarter+2026+Financial+Results+on+August+11%2C+2026/26793231.html</guid>
   <pubDate>Tue, 21 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Stereotaxis+to+Report+Second+Quarter+2026+Financial+Results+on+August+11%2C+2026/26793231.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  21, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=bhnQCBkUjyct7VX2izjefvwNrxr9af92644FSyyU3HySxsgMm-GtSi-c197ywFjwqzNp-5gpVN0l_QlexumndQ8Gv8nlJ0HlvITZm-de0pg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Stereotaxis, Inc.&lt;/a&gt; (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 second quarter on Tuesday, August 11, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the Company’s results and corporate developments.&lt;/p&gt; &lt;table style=&quot;border-collapse: collapse; width:100%; border-collapse:collapse ;&quot;&gt;&lt;tr&gt;&lt;td style=&quot;max-width:25%; width:25%; min-width:25%;;vertical-align: top ; &quot;&gt;&lt;strong&gt;What:&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;max-width:75%; width:75%; min-width:75%;;vertical-align: top ; &quot;&gt;Stereotaxis second</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Stereotaxis+to+Report+Second+Quarter+2026+Financial+Results+on+August+11%2C+2026/26793231.html</guid>
   <pubDate>Tue, 21 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Stereotaxis+to+Report+Second+Quarter+2026+Financial+Results+on+August+11%2C+2026/26793231.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  21, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=bhnQCBkUjyct7VX2izjefvwNrxr9af92644FSyyU3HySxsgMm-GtSi-c197ywFjwqzNp-5gpVN0l_QlexumndQ8Gv8nlJ0HlvITZm-de0pg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Stereotaxis, Inc.&lt;/a&gt; (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 second quarter on Tuesday, August 11, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the Company’s results and corporate developments.&lt;/p&gt; &lt;table style=&quot;border-collapse: collapse; width:100%; border-collapse:collapse ;&quot;&gt;&lt;tr&gt;&lt;td style=&quot;max-width:25%; width:25%; min-width:25%;;vertical-align: top ; &quot;&gt;&lt;strong&gt;What:&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;max-width:75%; width:75%; min-width:75%;;vertical-align: top ; &quot;&gt;Stereotaxis second</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Stereotaxis+to+Report+Second+Quarter+2026+Financial+Results+on+August+11%2C+2026/26793231.html</guid>
   <pubDate>Tue, 21 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Stereotaxis+to+Report+Second+Quarter+2026+Financial+Results+on+August+11%2C+2026/26793231.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  21, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=bhnQCBkUjyct7VX2izjefvwNrxr9af92644FSyyU3HySxsgMm-GtSi-c197ywFjwqzNp-5gpVN0l_QlexumndQ8Gv8nlJ0HlvITZm-de0pg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Stereotaxis, Inc.&lt;/a&gt; (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 second quarter on Tuesday, August 11, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the Company’s results and corporate developments.&lt;/p&gt; &lt;table style=&quot;border-collapse: collapse; width:100%; border-collapse:collapse ;&quot;&gt;&lt;tr&gt;&lt;td style=&quot;max-width:25%; width:25%; min-width:25%;;vertical-align: top ; &quot;&gt;&lt;strong&gt;What:&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;max-width:75%; width:75%; min-width:75%;;vertical-align: top ; &quot;&gt;Stereotaxis second</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Stereotaxis+to+Report+Second+Quarter+2026+Financial+Results+on+August+11%2C+2026/26793231.html</guid>
   <pubDate>Tue, 21 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>University of Szeged Pioneers First Robotic Cardiology Program in Hungary</title>
   <link>http://www.streetinsider.com/Press+Releases/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;First Robotic Magnetic Navigation system installed in Hungary&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;University of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using precision of robotics&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  20, 2026  (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch of the first advanced robotic cardiology program in Hungary at the University of Szeged in Szeged, Hungary.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Cardiology Center (Szent-Györgyi Albert Clinical Center) at the University of Szeged is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204654</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00164526</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>University of Szeged Pioneers First Robotic Cardiology Program in Hungary</title>
   <link>http://www.streetinsider.com/Press+Releases/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;First Robotic Magnetic Navigation system installed in Hungary&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;University of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using precision of robotics&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  20, 2026  (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch of the first advanced robotic cardiology program in Hungary at the University of Szeged in Szeged, Hungary.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Cardiology Center (Szent-Györgyi Albert Clinical Center) at the University of Szeged is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204654</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00164526</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>University of Szeged Pioneers First Robotic Cardiology Program in Hungary</title>
   <link>http://www.streetinsider.com/Press+Releases/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;First Robotic Magnetic Navigation system installed in Hungary&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;University of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using precision of robotics&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  20, 2026  (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch of the first advanced robotic cardiology program in Hungary at the University of Szeged in Szeged, Hungary.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Cardiology Center (Szent-Györgyi Albert Clinical Center) at the University of Szeged is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204654</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00164526</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>University of Szeged Pioneers First Robotic Cardiology Program in Hungary</title>
   <link>http://www.streetinsider.com/Press+Releases/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;First Robotic Magnetic Navigation system installed in Hungary&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;University of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using precision of robotics&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  20, 2026  (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch of the first advanced robotic cardiology program in Hungary at the University of Szeged in Szeged, Hungary.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Cardiology Center (Szent-Györgyi Albert Clinical Center) at the University of Szeged is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204654</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00164526</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>University of Szeged Pioneers First Robotic Cardiology Program in Hungary</title>
   <link>http://www.streetinsider.com/Globe+Newswire/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;First Robotic Magnetic Navigation system installed in Hungary&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;University of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using precision of robotics&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  20, 2026  (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch of the first advanced robotic cardiology program in Hungary at the University of Szeged in Szeged, Hungary.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Cardiology Center (Szent-Györgyi Albert Clinical Center) at the University of Szeged is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204654</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00164526</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>University of Szeged Pioneers First Robotic Cardiology Program in Hungary</title>
   <link>http://www.streetinsider.com/Globe+Newswire/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;First Robotic Magnetic Navigation system installed in Hungary&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;University of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using precision of robotics&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  20, 2026  (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch of the first advanced robotic cardiology program in Hungary at the University of Szeged in Szeged, Hungary.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Cardiology Center (Szent-Györgyi Albert Clinical Center) at the University of Szeged is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204654</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00164526</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>University of Szeged Pioneers First Robotic Cardiology Program in Hungary</title>
   <link>http://www.streetinsider.com/Globe+Newswire/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;First Robotic Magnetic Navigation system installed in Hungary&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;University of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using precision of robotics&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  20, 2026  (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch of the first advanced robotic cardiology program in Hungary at the University of Szeged in Szeged, Hungary.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Cardiology Center (Szent-Györgyi Albert Clinical Center) at the University of Szeged is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204654</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00164526</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>University of Szeged Pioneers First Robotic Cardiology Program in Hungary</title>
   <link>http://www.streetinsider.com/Globe+Newswire/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</link>
   <description>
&lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;First Robotic Magnetic Navigation system installed in Hungary&lt;/li&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;University of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using precision of robotics&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;ST. LOUIS, July  20, 2026  (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch of the first advanced robotic cardiology program in Hungary at the University of Szeged in Szeged, Hungary.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Cardiology Center (Szent-Györgyi Albert Clinical Center) at the University of Szeged is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/University+of+Szeged+Pioneers+First+Robotic+Cardiology+Program+in+Hungary/26787529.html</guid>
   <pubDate>Mon, 20 Jul 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204654</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00164526</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Form  8-K        Stereotaxis, Inc.         For: Jul 15</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stereotaxis%2C+Inc.+++++++++For%3A+Jul+15/26775810.html</link>
   <description>si-local-file:///var/storage/secattach/20260716/26775810.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stereotaxis%2C+Inc.+++++++++For%3A+Jul+15/26775810.html</guid>
   <pubDate>Thu, 16 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Form  8-K        Stereotaxis, Inc.         For: Jul 15</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stereotaxis%2C+Inc.+++++++++For%3A+Jul+15/26775810.html</link>
   <description>si-local-file:///var/storage/secattach/20260716/26775810.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stereotaxis%2C+Inc.+++++++++For%3A+Jul+15/26775810.html</guid>
   <pubDate>Thu, 16 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Form  S-3        Stereotaxis, Inc.                    </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Stereotaxis%2C+Inc.++++++++++++++++++++/26775031.html</link>
   <description>si-local-file:///var/storage/secattach/20260715/26775031.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Stereotaxis%2C+Inc.++++++++++++++++++++/26775031.html</guid>
   <pubDate>Wed, 15 Jul 2026 17:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Form  S-3        Stereotaxis, Inc.                    </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Stereotaxis%2C+Inc.++++++++++++++++++++/26775031.html</link>
   <description>si-local-file:///var/storage/secattach/20260715/26775031.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Stereotaxis%2C+Inc.++++++++++++++++++++/26775031.html</guid>
   <pubDate>Wed, 15 Jul 2026 17:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Form  S-3        Stereotaxis, Inc.                    </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Stereotaxis%2C+Inc.++++++++++++++++++++/26775012.html</link>
   <description>si-local-file:///var/storage/secattach/20260715/26775012.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Stereotaxis%2C+Inc.++++++++++++++++++++/26775012.html</guid>
   <pubDate>Wed, 15 Jul 2026 17:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Form  S-3        Stereotaxis, Inc.                    </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Stereotaxis%2C+Inc.++++++++++++++++++++/26775012.html</link>
   <description>si-local-file:///var/storage/secattach/20260715/26775012.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Stereotaxis%2C+Inc.++++++++++++++++++++/26775012.html</guid>
   <pubDate>Wed, 15 Jul 2026 17:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Form  8-K        Stereotaxis, Inc.         For: Jul 07</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stereotaxis%2C+Inc.+++++++++For%3A+Jul+07/26750560.html</link>
   <description>si-local-file:///var/storage/secattach/20260709/26750560.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stereotaxis%2C+Inc.+++++++++For%3A+Jul+07/26750560.html</guid>
   <pubDate>Thu, 09 Jul 2026 08:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Form  8-K        Stereotaxis, Inc.         For: Jul 07</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stereotaxis%2C+Inc.+++++++++For%3A+Jul+07/26750560.html</link>
   <description>si-local-file:///var/storage/secattach/20260709/26750560.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stereotaxis%2C+Inc.+++++++++For%3A+Jul+07/26750560.html</guid>
   <pubDate>Thu, 09 Jul 2026 08:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Stereotaxis completes acquisition of Robocath</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Stereotaxis+completes+acquisition+of+Robocath/26750541.html</link>
   <description>

&lt;p&gt;Stereotaxis (NYSE: STXS) announced it has completed its acquisition of Robocath, a France-based developer of robotic technologies for interventional cardiology and neurointerventions, according to a press release dated July 9, 2026.&lt;/p&gt;

&lt;p&gt;Robocath, founded in 2009 by Philippe Bencteux and headquartered in Rouen, France, will be fully integrated into Stereotaxis. The combined entity will cover robotic solutions across electrophysiology, interventional cardiology, and neurointerventions.&lt;/p&gt;

&lt;p&gt;Robocath's primary product, R-One, holds CE and NMPA certifications and is currently used in Europe and China. A meta-analysis cited in the press release reported a technical procedure success rate above 98% with no major adverse cardiovascular events.&lt;/p&gt;

&lt;p&gt;&quot;Combining the strengths,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Stereotaxis+completes+acquisition+of+Robocath/26750541.html</guid>
   <pubDate>Thu, 09 Jul 2026 08:08:14 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Stereotaxis completes acquisition of Robocath</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Stereotaxis+completes+acquisition+of+Robocath/26750541.html</link>
   <description>

&lt;p&gt;Stereotaxis (NYSE: STXS) announced it has completed its acquisition of Robocath, a France-based developer of robotic technologies for interventional cardiology and neurointerventions, according to a press release dated July 9, 2026.&lt;/p&gt;

&lt;p&gt;Robocath, founded in 2009 by Philippe Bencteux and headquartered in Rouen, France, will be fully integrated into Stereotaxis. The combined entity will cover robotic solutions across electrophysiology, interventional cardiology, and neurointerventions.&lt;/p&gt;

&lt;p&gt;Robocath's primary product, R-One, holds CE and NMPA certifications and is currently used in Europe and China. A meta-analysis cited in the press release reported a technical procedure success rate above 98% with no major adverse cardiovascular events.&lt;/p&gt;

&lt;p&gt;&quot;Combining the strengths,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Stereotaxis+completes+acquisition+of+Robocath/26750541.html</guid>
   <pubDate>Thu, 09 Jul 2026 08:08:14 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Stereotaxis Completes Acquisition of Robocath</title>
   <link>http://www.streetinsider.com/Press+Releases/Stereotaxis+Completes+Acquisition+of+Robocath/26750539.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;ST. LOUIS and ROUEN, France, July  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=2mAcM9bYgs0jKzvdiabZSIjqS50XDKqXKU_O-8NcVAZlYxEqDjYoyqrpBw2qhU8KMnop59rkfVCAqh7iVL9AQxGC9gN-vWIqTFFp6Kv0dMg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Stereotaxis&lt;/a&gt; (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has completed its previously announced acquisition of Robocath, an innovator of robotic technologies for interventional cardiology and neurointerventions.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Robocath will now be fully integrated into Stereotaxis, combining complementary technologies and expertise to accelerate the development of next-generation robotic solutions for electrophysiology, interventional cardiology, and neurointerventions. The combined platform strengthens Stereotaxis’s position as the leader in robotic technologies across the full</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Stereotaxis+Completes+Acquisition+of+Robocath/26750539.html</guid>
   <pubDate>Thu, 09 Jul 2026 08:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Stereotaxis Completes Acquisition of Robocath</title>
   <link>http://www.streetinsider.com/Press+Releases/Stereotaxis+Completes+Acquisition+of+Robocath/26750539.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;ST. LOUIS and ROUEN, France, July  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=2mAcM9bYgs0jKzvdiabZSIjqS50XDKqXKU_O-8NcVAZlYxEqDjYoyqrpBw2qhU8KMnop59rkfVCAqh7iVL9AQxGC9gN-vWIqTFFp6Kv0dMg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Stereotaxis&lt;/a&gt; (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has completed its previously announced acquisition of Robocath, an innovator of robotic technologies for interventional cardiology and neurointerventions.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Robocath will now be fully integrated into Stereotaxis, combining complementary technologies and expertise to accelerate the development of next-generation robotic solutions for electrophysiology, interventional cardiology, and neurointerventions. The combined platform strengthens Stereotaxis’s position as the leader in robotic technologies across the full</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Stereotaxis+Completes+Acquisition+of+Robocath/26750539.html</guid>
   <pubDate>Thu, 09 Jul 2026 08:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
  <item>
   <title>Stereotaxis Completes Acquisition of Robocath</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Stereotaxis+Completes+Acquisition+of+Robocath/26750539.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;ST. LOUIS and ROUEN, France, July  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=2mAcM9bYgs0jKzvdiabZSIjqS50XDKqXKU_O-8NcVAZlYxEqDjYoyqrpBw2qhU8KMnop59rkfVCAqh7iVL9AQxGC9gN-vWIqTFFp6Kv0dMg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Stereotaxis&lt;/a&gt; (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has completed its previously announced acquisition of Robocath, an innovator of robotic technologies for interventional cardiology and neurointerventions.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Robocath will now be fully integrated into Stereotaxis, combining complementary technologies and expertise to accelerate the development of next-generation robotic solutions for electrophysiology, interventional cardiology, and neurointerventions. The combined platform strengthens Stereotaxis’s position as the leader in robotic technologies across the full</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Stereotaxis+Completes+Acquisition+of+Robocath/26750539.html</guid>
   <pubDate>Thu, 09 Jul 2026 08:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05078246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STXS</category>
   	  </item>
 </channel>
</rss>
